Skip to main content

Frontiers of Medicine

Ausgabe 4/2017

Inhalt (16 Artikel)

Human monoclonal antibodies as candidate therapeutics against emerging viruses

  • Review

Yujia Jin, Cheng Lei, Dan Hu, Dimiter S. Dimitrov, Tianlei Ying

Current advances in the elimination of hepatitis B in China by 2030

  • Review

Shuye Zhang, Fusheng Wang, Zheng Zhang

Application of liquid biopsy in precision medicine: opportunities and challenges

  • Review

Junyun Wang, Shuang Chang, Guochao Li, Yingli Sun

Irreversible phenotypic perturbation and functional impairment of B cells during HIV-1 infection

  • Research Article

Jingjing Yan, Shuye Zhang, Jun Sun, Jianqing Xu, Xiaoyang Zhang

Impact of HBV replication in peripheral blood mononuclear cell on HBV intrauterine transmission

  • Research Article

Xiaohong Shi, Xuefei Wang, Xixi Xu, Yongliang Feng, Shuzhen Li, Shuying Feng, Bo Wang, Suping Wang

CRISPR-Cas9 mediated LAG-3 disruption in CAR-T cells

  • Research Article

Yongping Zhang, Xingying Zhang, Chen Cheng, Wei Mu, Xiaojuan Liu, Na Li, Xiaofei Wei, Xiang Liu, Changqing Xia, Haoyi Wang

Propensity score-matched study and meta-analysis of cumulative outcomes of day 2/3 versus day 5/6 embryo transfers

  • Research Article

Ye Yin, Ge Chen, Kezhen Li, Qiuyue Liao, Sijia Zhang, Nieying Ma, Jing Chen, Yan Zhang, Jihui Ai

Strategies of minimally invasive treatment for intrahepatic and extrahepatic bile duct stones

  • Commentary

Zongming Zhang, Zhuo Liu, Limin Liu, Mengmeng Song, Chong Zhang, Hongwei Yu, Baijiang Wan, Mingwen Zhu, Zixu Liu, Hai Deng, Haiming Yuan, Haiyan Yang, Wenping Wei, Yue Zhao